Notre actualité
There are many things to perform today using Artificial Intelligence (AI), especially in health and drug discovery domains (but only if you understand the technologies!). If you want to improve your knowledge in the field during the summer, I recommend you read the “AI, ML & Deep learning Community of Read more…
We were invited at the workshop organized by SMILL-E (Seeding Microsystems in Medecine in Lille – European-Japanese Technologies against Cancer) and Yncrea during MedFit event last week. This great workshop was about Digital and Micro systems for LifeTECH. Elodie was there to talk about innovative technologies for the screening of Read more…
Atopic dermatitis (AD) is a chronic, common inflammatory skin disease affecting 15-20% of children and 1-3% of adults worldwide. Loss of bacterial diversity from excess abundance of Staphylococcus aureus is associated with increased disease severity, nevertheless, how dysbiosis of the skin microbiome may influence atopic dermatitis pathophysiology is unknown. In Read more…
Elodie, Véronique et Océane ont profité d’un moment très sympathique – et ensoleillé – lors du barbecue du parc Eurasanté ce midi… Merci à tous, et bon week-end 🙂
Last week we were pleased to attend the founding congress of STCM (Société de Toxicologie Cellularie et Moléculaire), which was held in FIAP Jean Monnet (Paris). The topic was “Toxicology towards the 3rd dimension“. With a wide variety of talks from academic laboratories and from the industry, the content was Read more…
The founding congress of the french STCM (Société de Toxicologie Cellulaire et Moléculaire) will take place in Paris at the end of this week (13th-14th June, 2019). The theme of this meeting will be “Toxicology towards the 3rd dimension“. We are looking forward to attending this congress, and to becoming Read more…
We will be present this week and next week in Rotterdam, to talk about 3D cell culture and the importance of the microenvironnement in the relevance of in vitro models. As you known, to mimic human tissues, several parameters need to be taken into account: the target cells, nutrient intake Read more…
The 16th SFBMEC congress was held last week in Reims: Elodie and Zied attended the meeting to be aware of the last trends in extracellular matrix (ECM) research and industry and medical applications. And they were not disappointed! After a first touching lecture in memoriam of the late Ladislas Robert Read more…
Our study director Elodie really enjoyed Vitafoods last week in Geneva, and the welcome she had on the different booths she visited along the three days! The show was very impressive, with a wide variety of exhibitors (more than 1.000 companies) and more than 20.000 visitors! Elodie spent much time Read more…
You should know Science Exchange, the world’s leading and most secure platform for outsourced research, providing large R&D organizations with the fastest path from discovery through development and commercialization. Now, we are very proud to provide our most innovative services on the platform! We will find: 3D Cell Culture Models Read more…
We will be at Vitafoods Europe 2019 next week in Geneva. It’s a big opportunity to discover our services in nutraceticals and dermocosmetology. This year Vitafoods Europe will focus on sustainability, it’s why we will emphasis the presentation of our completely physiological BIOMIMESYS® hydroscaffold for 3D cell culture. We will Read more…
The annual SCMC congress (Société Cerveau et Maladies Cérébrovasculaires – Brain and Cerebrovascular diseases Society) took place in Lille last week, in the Faculty of Medecine. The congress was organized in three sessions. The first session was about cerebrovascular development and maturation. The conferences began with a lecture about blood-brain Read more…
Last week HCS Pharma team enjoyed Forum Labo Paris! We enjoyed it twofold because : we won our booth on the Lab’StartUp Village, in the heart of the fair. It gave us the opportunity to present our BIOMIMESYS® products! we won a price for our amazing photo of liver cells… Read more…
We will be happy to meet you at In-cosmetics Global at Porte de Versailles this week from 2nd-4th of April (https://www.in-cosmetics.com/global/) and to present you our multiplex offer (based on in vitro automated cell Imaging) that permit to evaluate simultaneously one active ingredient or raw extract for different marketing claims Read more…
Our CEO, Nathalie, has presented company strategy in front of many investors at Start West event in Rennes. She explained especially why our next fund rising is mandatory to develop internationally our exclusive BIOMIMESYS® products. She also shared with attendees her vision of the necessity of 3D cell culture to Read more…
Véronique De Conto, doctorante chez HCS Pharma, présentera ce jeudi 28 mars à Lille, au congrès annuel de la Société Cerveau et Maladies Cérébrovasculaires, le développement d’un modèle cérébral en 3 dimensions incluant le microenvironnement matriciel pour la recherche de nouveaux médicaments contre la maladie de Parkinson. Introduction : 90% Read more…
Next week HCS Pharma will be present both at Forum Labo Paris (26th-28th March ) and at SCMC congress in Lille (28-29th March)! In Forum Labo we will have our own stand in the Lab’StartUp Village (stand G11), thanks to the organizers for selecting BIOMIMESYS® Brain for the fair! We Read more…
Victoria has joined us for a six-month internship in collaboration with the University of Technology of Compiègne. She will develop a liver biochip, using the BIOMIMESYS® Liver hydroscaffold. Victoria obtained her bachelor’s degree in Cellular Biology and Physiology. Currently she is finishing the 2nd year of Master’s Degree in Biotechnologies Read more…
The first version of BIOMIMESYS Brain allows to form neurospheres. We now developped a new version of BIOMIMESYS Brain, which allows to form neuronal networks. This version have a higher porosity than BIOMIMESYS Brain (Neurosphere), that allows to better disperse the cells and thus to form cell network instead of Read more…
After a bachelor of science in biology, Solenne has been graduated with a two-year diploma “DUT Génie Biologique”, specialized in biological and biochemistry analysis. Afterwards, she wenty on with a professional bachelor’s degree dealing with the development of cosmetic and health products at Université Bretagne Sud in Vannes, where she Read more…
Jean-Baptise obtained his Master’s degree in Cellular and Molecular Biology at Paris-Sorbonne University in 2018 after a six-month internship with us. He focused on the development of a human microbiota model in collaboration with the Pharmacology Lab of University of Rennes 1 (INSERM U1230). He will keep on working on Read more…
BIOMIMESYS® Oncology is mostly composed of hyaluronic acid (HA), biofunctionnalized with undenaturated collagen I. HA, by interacting with its binding proteins (CD44, RHAMM, ICAM-1), is an active participant in inflammatory, angiogenic, fibrotic and cancer-promoting processes (Figure 1). We are currently looking at the effect of different elastic moduli of BIOMIMESYS® Read more…
HCS Pharma is one of the winner of the Lab’StartUp village, organized by Forum Labo! As such, we have won a stand in the heart of the forum (March 26-28, 2019)… Thanks a lot to the committee for evaluating our application to this prize, and for selecting our new product Read more…